Innovating Works

CHULALONGKORN UNIVERSITY

Desconocido
THERABOT: Therapeutic Bacteria Biohybrids For Oncology Treatment THERABOT pioneers a groundbreaking approach in the fight against cancer through the development of engineered biohybrid agents, iBots. These...
2024-07-02 - 2028-12-31 | Financiado
WhyNotDry: Toward consolidation of germplasm and cell reversible drying through knowledge transfer. CHULALONGKORN UNIVERSITY participó en un HORIZON EUROPE: HORIZON-MSCA-2022-SE-01 WhyNotDry will deepen our knowledge on reversible drying in cells and germplasm toward the development of a dry biobanking as an alternative...
2023-08-02 - 2027-09-30 | Financiado
SHIFT: Shaping Innovative Designs for Sustainable Tissue Engineering Products CHULALONGKORN UNIVERSITY participó en un H2020: H2020-MSCA-RISE-2020 Shaping Innovative Products for Sustainable Tissue Engineering Strategies - SHIFT is the follow up of MSCA-RISE REMIX (GA 778078). While REM...
2020-11-11 - 2025-08-31 | Financiado
LABOUR: Tackling informal employment in Asia building post COV19 solutions to precariousness through case s... CHULALONGKORN UNIVERSITY participó en un H2020: H2020-MSCA-RISE-2020 According to the last WESO report, there are over 1.4bn workers in vulnerable jobs worldwide, with numbers expected to rise in 2020 due to C...
2020-11-09 - 2025-12-31 | Financiado
SUPRO-GEN: Supramolecular Polyamine Gene Vectors for Cancer Therapy CHULALONGKORN UNIVERSITY participó en un H2020: H2020-MSCA-RISE-2020 Gene therapy, most commonly using viral vectors, can be applied to inhibit or edit the expression of any gene of interest, being highly spec...
2020-10-26 - 2026-02-28 | Financiado
OXIGENATED: Hemoglobin based Protein Nanocarriers for Tumour Oxygenation and a more effective Photodynamic Thera... CHULALONGKORN UNIVERSITY participó en un H2020: H2020-MSCA-RISE-2018 A major drawback of Photodynamic Therapy (PDT) and other therapies for cancer treatment is the limited oxygen content, hypoxia, in tumour ti...
2018-09-18 - 2024-08-31 | Financiado
REMIX: Regenerative Medicine Innovation Crossing Research and Innovation Staff Exchange in Regenerative M... CHULALONGKORN UNIVERSITY participó en un H2020: H2020-MSCA-RISE-2017 Natural materials in biomedical field are investigated for clinical use, as materials for the fabrication of biomedical prostheses, for the...
2017-10-25 - 2023-04-30 | Financiado
DRYNET: Setting an interdisciplinary sectorial international research network to explore dry storage as an... CHULALONGKORN UNIVERSITY participó en un H2020: H2020-MSCA-RISE-2016 The number of biobanks for diagnostic/clinical/biodiversity preservation purposes is increasing exponentially, representing an economic burd...
2016-11-10 - 2022-08-31 | Financiado
TASCMAR: Tools And Strategies to access to original bioactive compounds from Cultivation of MARine invertebra... CHULALONGKORN UNIVERSITY participó en un H2020: H2020-BG-2014-2015 TASCMAR project aspires to develop new tools and strategies in order to overcome existing bottlenecks in the biodiscovery and industrial exp...
2015-02-23 - 2019-09-30 | Financiado
LIMPID: Nanocomposite materials for photocatalytic degradation of pollutants CHULALONGKORN UNIVERSITY participó en un FP7: Limpid aims at generating new knowledge on photocatalytic materials and processes in order to develop novel depollution treatments with enha...
Financiado
PARTNERS: Comparative embryonic stem cell research in mammalians CHULALONGKORN UNIVERSITY participó en un FP7: The PartnErS project is aimed at creating a mutually beneficial training and transfer of knowledge program between a Hungarian SME and a Dan...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.